QA: Immune Design CORP in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001437786_2019_Immune_Design_CORP.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}

Graph

Absolute values for 0001437786, Immune Design CORP

  xvar xval
0 AssetsCurrent 100,225,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 535,000
3 remainder_Assets 200,000
4 LiabilitiesCurrent 8,845,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 1,435,000
8 SellingGeneralAndAdministrativeExpense 15,358,297
9 ResearchAndDevelopmentExpense 41,423,137
10 remainder_Expenses -34,880
11 remainder_Revenues -876,341
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 9,329,578
  yvar yval
0 Assets 100,960,000
1 Liabilities 8,845,000
2 Expenses 58,181,554
3 Revenues -876,341
4 StockholdersEquity 92,115,000
5 NetIncome -59,057,895
6 ComprehensiveNetIncome -54,393,106
7 BaseVar 89,096,236
8 EconomicCapitalRatiobeforeLimitedLiability 2.67
9 EconomicCapitalRatio 3.47

Edgar->Model Mapping

Feature Distribution

Change over Time